| Product Code: ETC7555574 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India tinea corporis drugs market import shipment demonstrated a gradual growth trend with a CAGR from 2020 to 2024 of 0.9. Notably, between 2023 and 2024, the growth rate increased by 6.3, indicating a significant acceleration in market expansion during the latter period. Overall, the market exhibited a stable growth trajectory with a notable uptick in momentum towards the end of the analyzed period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Tinea Corporis Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Tinea Corporis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Tinea Corporis Drugs Market - Industry Life Cycle |
3.4 India Tinea Corporis Drugs Market - Porter's Five Forces |
3.5 India Tinea Corporis Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Tinea Corporis Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Tinea Corporis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about skin infections and the importance of early treatment |
4.2.2 Rising prevalence of tinea corporis cases in India |
4.2.3 Growing disposable income leading to higher healthcare spending |
4.3 Market Restraints |
4.3.1 Presence of alternative treatment options such as home remedies and traditional medicine |
4.3.2 Lack of awareness about specific tinea corporis drugs and their effectiveness |
5 India Tinea Corporis Drugs Market Trends |
6 India Tinea Corporis Drugs Market, By Types |
6.1 India Tinea Corporis Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Tinea Corporis Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Tinea Corporis Drugs Market Revenues & Volume, By Antifungals, 2021- 2031F |
6.1.4 India Tinea Corporis Drugs Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.5 India Tinea Corporis Drugs Market Revenues & Volume, By Anti-Infective Combinations, 2021- 2031F |
6.2 India Tinea Corporis Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Tinea Corporis Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 India Tinea Corporis Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 India Tinea Corporis Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Tinea Corporis Drugs Market Import-Export Trade Statistics |
7.1 India Tinea Corporis Drugs Market Export to Major Countries |
7.2 India Tinea Corporis Drugs Market Imports from Major Countries |
8 India Tinea Corporis Drugs Market Key Performance Indicators |
8.1 Number of dermatology clinics offering treatments for tinea corporis |
8.2 Percentage of population undergoing treatment for tinea corporis |
8.3 Research and development investment in new tinea corporis drugs |
9 India Tinea Corporis Drugs Market - Opportunity Assessment |
9.1 India Tinea Corporis Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Tinea Corporis Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Tinea Corporis Drugs Market - Competitive Landscape |
10.1 India Tinea Corporis Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Tinea Corporis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here